Literature DB >> 24078665

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

B Glimelius1, E Tiret, A Cervantes, D Arnold.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24078665     DOI： 10.1093/annonc/mdt240

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  153 in total

1.  Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer.

Authors:  Hiroshi Doi; Naohito Beppu; Takashi Kato; Masashi Noda; Hidenori Yanagi; Naohiro Tomita; Norihiko Kamikonya; Shozo Hirota
Journal:  Mol Clin Oncol       Date:  2015-07-21

2.  The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.

Authors:  Daniel H Ahn; Christina Wu; Lai Wei; Terence M Williams; Evan Wuthrick; Sherif Abdel-Misih; Alan Harzman; Syed Husain; Carl Schmidt; Richard M Goldberg; Tanios Bekaii-Saab
Journal:  Am J Clin Oncol       Date:  2017-12       Impact factor: 2.339

3.  Re-irradiation With Carbon Ion Radiotherapy for Pelvic Rectal Cancer Recurrences in Patients Previously Irradiated to the Pelvis.

Authors:  Amelia Barcellini; Viviana Vitolo; Lorenzo Cobianchi; Andrea Peloso; Alessandro Vanoli; Alfredo Mirandola; Angelica Facoetti; Maria Rosaria Fiore; Alberto Iannalfi; Barbara Vischioni; Francesco Cuccia; Sara Ronchi; Maria Bonora; Giulia Riva; Rachele Petrucci; Emma D'Ippolito; Francesca Dal Mas; Lorenzo Preda; Francesca Valvo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 4.  Evolution of imaging in rectal cancer: multimodality imaging with MDCT, MRI, and PET.

Authors:  Siva P Raman; Yifei Chen; Elliot K Fishman
Journal:  J Gastrointest Oncol       Date:  2015-04

5.  A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2017-07-21       Impact factor: 2.935

6.  Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.

Authors:  Vincenzo Formica; Michaela Benassi; Giovanna Del Vecchio Blanco; Elena Doldo; Laura Martano; Ilaria Portarena; Antonella Nardecchia; Jessica Lucchetti; Cristina Morelli; Emilia Giudice; Piero Rossi; Alessandro Anselmo; Pierpaolo Sileri; Giuseppe Sica; Augusto Orlandi; Riccardo Santoni; Mario Roselli
Journal:  Med Oncol       Date:  2018-05-02       Impact factor: 3.064

7.  Retrospective Comparison of mFOLFOXIRI With XELOX/SOX as Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.

Authors:  Hiroyuki Kodama; Tetsuji Terazawa; Yasunobu Ishizuka; Hiroki Yukami; Masahiko Aoki; Takahiro Miyamoto; Toshifumi Yamaguchi; Futukaro Shimamoto; Takayuki Kii; Masahiro Goto; Hiroki Hamamoto; Wataru Osumi; Masashi Yamamoto; Keitaro Tanaka; Jyunji Okuda; Kazuhisa Uchiyama; Kazuhide Higuchi
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 8.  Controversies in the multimodality management of locally advanced rectal cancer.

Authors:  Robert Díaz Beveridge; Dilara Akhoundova; Gema Bruixola; Jorge Aparicio
Journal:  Med Oncol       Date:  2017-04-24       Impact factor: 3.064

9.  Long-term functional follow-up after anterior rectal resection for cancer.

Authors:  Alessandro Sturiale; Jacopo Martellucci; Letizia Zurli; Carla Vaccaro; Luigi Brusciano; Paolo Limongelli; Ludovico Docimo; Andrea Valeri
Journal:  Int J Colorectal Dis       Date:  2016-09-30       Impact factor: 2.571

10.  Outcome of bowel function following anterior resection for rectal cancer-an analysis using the low anterior resection syndrome (LARS) score.

Authors:  Juliane Kupsch; Thomas Jackisch; Klaus E Matzel; Joerg Zimmer; Andreas Schreiber; Anja Sims; Helmut Witzigmann; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2018-03-15       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.